The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
AI chatbots can generate quality, empathetic, readable responses
May 17, 2024
Chatbots can generate quality responses to cancer patient questions, comparable to physician responses.
More medical lab tests will soon face federal scrutiny, FDA says
Apr 29, 2024
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by the US Food and Drug Administration, the agency announced Monday.
New prostate cancer urine test has high diagnostic accuracy
Apr 22, 2024
A higher AUROC was seen for the 18-gene MPS2 model compared with current guideline-endorsed biomarkers.
AI could help ease seniors’ concerns before they receive cancer treatment
By
Aaron Dorman
Apr 10, 2024
AI may be able to assist seniors’ caregivers in offering support and information about cancer and radiation treatment, a new study shows.
Virtual sessions lessen seniors’ cancer pain, study finds
By
Aaron Dorman
Apr 10, 2024
A 10-minute VR session was able to provide lasting pain relief for cancer patients, offering an alternative to opioids, a new study showed.
AI ability to mimic empathy worries, rather than comforts, many researchers
By
Aaron Dorman
Apr 04, 2024
Two studies evaluated AI’s use in two very important care contexts, mental health and cancer care, and noted concerns about mimicking empathy.
ChatGPT performs well in answering genetic testing questions
Mar 22, 2024
ChatGPT performance was equally accurate for fact-based and counseling-type questions regarding gynecologic cancers.
FDA: Food packaging containing PFAS no longer sold in the United States
Feb 28, 2024
“Forever chemicals” are tied to a host of health issues and are slow to degrade in the environment.
Concierge services and virtual care options can improve access to high-value specialty care: survey
By
Aaron Dorman
Feb 26, 2024
Although most people who have serious condition diagnoses are open to a specialty care via telehealth, less than half of them end up doing so.